Global Patent Index - EP 1015642 A1

EP 1015642 A1 2000-07-05 - MEANS AND METHODS FOR MONITORING NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS

Title (en)

MEANS AND METHODS FOR MONITORING NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS

Title (de)

MITTEL UND METHODEN ZUR AUFZEICHNUNG EINER ANTIRETROVIRALEN THERAPIE MIT NUCLEOSID-REVERSE TRANSKRIPTASE-INHIBITOREN UND LEITFADEN ZU THERAPEUTISCHEN ENTSCHEIDUNGEN IN DER HIV/AIDS-BEHANDLUNG

Title (fr)

METHODES ET MOYENS POUR CONTROLER UNE THERAPIE ANTIRETROVIRALE UTILISANT L'INHIBITEUR DE LA REVERSE-TRANSCRIPTASE NUCLEOSIDIQUE, ET POUR OPERER DES CHOIX THERAPEUTIQUES DANS LE TRAITEMENT DU VIH/SIDA

Publication

EP 1015642 A1 (EN)

Application

EP 99933581 A

Priority

  • US 9914486 W
  • US 10429598 A

Abstract (en)

[origin: WO9967427A1] This invention relates to antiviral drug susceptibility and resistance tests to be used in identifying effective drug regimens for the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) and further relates to the means and methods of monitoring the clinical progression of HIV infection and its response to antiretroviral therapy, particularly nucleoside reverse transcriptase inhibitor therapy using phenotypic susceptibility assays or genotypic assays.

IPC 1-7 (main, further and additional classification)

C12Q 1/68; A01N 43/04; C07H 21/02; C07H 21/04; C12N 13/00; C12Q 1/70

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); A01N 43/04 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C08G 18/12 (2006.01); C09J 4/06 (2006.01); C12N 13/00 (2006.01); C12N 15/09 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); G01N 33/15 (2006.01)

CPC (invention and additional information)

C12Q 1/703 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9967427 A1 19991229; WO 9967427 A9 20000330; AU 4961199 A 20000110; AU 769927 B2 20040212; BR 9912209 A 20021105; CA 2341679 A1 19991229; CN 1154747 C 20040623; CN 1332804 A 20020123; EP 1015642 A1 20000705; EP 1015642 A4 20050323; JP 2003503004 A 20030128; MX PA00012843 A 20020424; NZ 508981 A 20040227

INPADOC legal status


2009-06-10 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20081210

2007-06-13 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20050923

2007-02-02 [REG HK WD] APPLICATIONS WITHDRAWN, DEEMED TO BE WITHDRAWN, OR REFUSED AFTER PUBLICATION IN HONG KONG

- Document: HK 1030631

2006-08-09 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: MONOGRAM BIOSCIENCES, INC.

2005-03-23 [A4] SUPPLEMENTARY SEARCH REPORT

- Effective date: 20050202

2000-07-05 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000313

2000-07-05 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE